

Terumo India has launched Ultimaster Nagomi™, a Drug-Eluting Stent for treating coronary artery disease. With cardiovascular disease causing 25% of all deaths in India, the new stent aims to enhance the safety and effectiveness of coronary artery treatments. The Ultimaster Nagomi™ is designed to navigate complex arteries and adapt to any vessel size, allowing for customized stent selection.


Terumo India has launched Ultimaster Nagomi™, a Drug-Eluting Stent for treating coronary artery disease. With cardiovascular disease causing 25% of all deaths in India, the new stent aims to enhance the safety and effectiveness of coronary artery treatments. The Ultimaster Nagomi™ is designed to navigate complex arteries and adapt to any vessel size, allowing for customized stent selection.
•The stent aims to enhance the safety and effectiveness of coronary artery treatments.
•Ultimaster Nagomi™ can navigate complex arteries and adapt to any vessel size.
•It allows for customized stent selection for a larger patient subset.
•Cardiovascular disease causes 25% of all deaths in India, with a prevalence of around 54.5 million in the country.







